Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction

doi:10.5527/wjn.v4.i3.330

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13079)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-22) series, Tables (1-1) series.

Item

Count

PDF

1122

WORD

370

HTML

8620

Figures (1-22)

310

Tables (1-1)

175

Sum=10597

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1103

Download

1379

Sum=2482

Jul 6, 2015 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. Jul 6, 2015; 4(3): 330-344
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.330

Full Size Figure Download Figure

Figure 7 The dose after dialysis (D_HD) replaces both the dose adjusted for kidney failure (D_fail), and the supplementary dose (D_suppl) that compensates for the fraction (FR) removed during hemodialysis (HD).

Citation: Keller F, Schröppel B, Ludwig U. Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction. World J Nephrol 2015; 4(3): 330-344
URL: https://www.wjgnet.com/2220-6124/full/v4/i3/330.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i3.330